<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01527396</url>
  </required_header>
  <id_info>
    <org_study_id>KGOG2015</org_study_id>
    <nct_id>NCT01527396</nct_id>
  </id_info>
  <brief_title>Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer</brief_title>
  <acronym>PALME</acronym>
  <official_title>Multi-center Prospective Observational Study for the Validation of Preoperative Low-risk Criteria for Lymph Node Metastasis in Endometrial Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korean Gynecologic Oncology Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of low risk criteria for lymph node
      metastasis, that was determined by KGOG-2014 retrospective study, in women with endometrial
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Korean Gynecologic Oncology Group (KGOG) undertook a multi-center retrospective study to
      develop a preoperative prediction model for lymph node metastasis in endometrial cancer
      (KGOG-2014). This retrospective multi-center study showed that the accurate identification of
      a low-risk group for lymph node metastasis among the patients with endometrial cancer can be
      achieved with the new criteria using preoperative MRI and serum CA-125 assay. In this study,
      serum CA125 levels and three MRI parameters (deep myometrial invasion, lymph node
      enlargement, and extension beyond uterine corpus) were found to be independent risk factors
      for nodal metastasis. Based on the success of KGOG-2014, Korean Gynecologic Oncology Group
      initiated this prospective, multi-center observational study to validate our prior prediction
      model.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity/Specificity</measure>
    <time_frame>2014-12-31</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative predictive value</measure>
    <time_frame>2014-12-31</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic odds ratio</measure>
    <time_frame>2014-12-31</time_frame>
  </primary_outcome>
  <enrollment type="Actual">529</enrollment>
  <condition>Endometrial Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Endometrial cancer patients who undergo surgery including systemic lymph node dissection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a histologic diagnosis of endometrial cancer before surgical staging.

          -  Patients with a preoperative magnetic resonance imaging (MRI) and serum CA-125 within
             4 weeks from surgical staging.

          -  Patients who underwent adequate systemic lymph node dissection during surgical
             staging.

        Exclusion Criteria:

          -  Patients with a histologic feature suggesting sarcoma or squamous cell carcinoma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sokbom Kang</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Korean Gynecologic Oncology Group</name>
      <address>
        <city>Seoul</city>
        <state>Kangnam-gu</state>
        <zip>135010</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2012</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <last_update_submitted>October 27, 2015</last_update_submitted>
  <last_update_submitted_qc>October 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Sokbom Kang</investigator_full_name>
    <investigator_title>Director, Gynecologic Oncology Research Div.</investigator_title>
  </responsible_party>
  <keyword>endometrial cancer</keyword>
  <keyword>lymph node metastasis</keyword>
  <keyword>lymphadenectomy</keyword>
  <keyword>risk criteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

